Search Bar & Filters
Found 1 Actively Recruiting clinical trials
Actively Recruiting
Researchers are studying the best timing for vitrectomy surgery to remove symptomatic epiretinal membranes ERM, a condition affecting the retina that can cause visual distortion and loss. The trial compares immediate surgery to deferred surgery, which is usually recommended when vision worsens to 2040 or worse. The study aims to understand how delaying surgery impacts visual outcomes, identify factors predicting surgery success or disease progression, and evaluate new measures of visual distortion and reading speed in this condition. Participants are randomly assigned to one of two groups immediate vitrectomy surgery within one month of randomization, or deferred vitrectomy where surgery is performed only if vision declines significantly, symptoms worsen, or complications arise. The deferred group is closely monitored to detect changes that would trigger surgery. This approach helps researchers compare outcomes between early and delayed surgical intervention for ERM. During the study, participants undergo regular vision assessments, including evaluating visual acuity changes over 36 months, which is the primary outcome measure. Researchers also collect data on visual distortion and reading speed to better understand symptoms. Safety and progression are closely monitored, and surgery timing decisions are guided by defined criteria or participant preference. The total study duration extends up to three years, providing long-term insight into ERM management.